SBTX — Skinbiotherapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- £19.54m
- £16.79m
- £0.13m
2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | Interim Report | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 3.12 | 2.16 | 4.61 | 1.8 | 1.31 |
Net Total Receivables | 0.453 | 0.141 | 0.453 | 0.405 | 0.375 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 3.58 | 2.35 | 5.06 | 2.33 | 1.72 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.007 | 0.002 | 0.143 | 0.127 | 0.173 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 3.93 | 2.77 | 5.73 | 3.08 | 2.59 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.121 | 0.305 | 0.405 | 0.509 | 0.53 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.121 | 0.305 | 0.52 | 0.61 | 0.599 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 3.81 | 2.47 | 5.22 | 2.48 | 1.99 |
Total Liabilities & Shareholders' Equity | 3.93 | 2.77 | 5.73 | 3.08 | 2.59 |
Total Common Shares Outstanding |